Study of a New Anticoagulant Drug in Patients With Atrial Fibrillation

Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF)

NCT03508258 ·Status: WITHDRAWN

Atrial Fibrillation Research Database

NCT03760874 ·Status: UNKNOWN

A Study to Quantify Use of Anticoagulation to Improve Management of Atrial Fibrillation

NCT03382613 ·Status: TERMINATED

Prediction of Bleeding Risk After Anticoagulant Therapy for Atrial Fibrillation Based on Proteomics and Metabolomics

NCT05181774 ·Status: UNKNOWN

Application of "I-Anticoagulation"in Patients With Atrial Fibrillation

NCT06137794 ·Status: NOT_YET_RECRUITING ·Phase: NA

Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation

NCT02347111 ·Status: RECRUITING ·Phase: PHASE4

Use of Oral Anticoagulants and Symptoms in Patients With Atrial Fibrillation in Örebro County

NCT04233515 ·Status: COMPLETED

Atrial Fibrillation in Relationship to Plasma Biomarkers

NCT04710745 ·Status: UNKNOWN

COhort of antithrOmbotic Use and cLinical Outcomes in Patients With Atrial Fibrillation (COOL-AF) Phase 2

NCT06396299 ·Status: RECRUITING

Efficacy and Safety of Azimilide for the Treatment of Patients With Atrial Fibrillation

NCT00035477 ·Status: COMPLETED ·Phase: PHASE3

Oral Anticoagulation Therapy Pilot Study

NCT01959425 ·Status: TERMINATED ·Phase: PHASE4

A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation

NCT00938730 ·Status: COMPLETED ·Phase: PHASE2

Management of Antithrombotic TherApy in Patients With Atrial Fibrillation or DevelOping AtRial Fibrillation During Hospitalization for PCI

NCT03656523 ·Status: COMPLETED

Genetically Determined Response to Atenolol in Patients With Persistent Atrial Fibrillation

NCT01719367 ·Status: COMPLETED ·Phase: NA

Use of Anticoagulant, and Associated Factors of Anticoagulant Refusal Atrial Fibrillation Patients

NCT04062071 ·Status: UNKNOWN

Relationship Between Renal Function and Pharmacokinetics of Apixaban and Clinical Outcome of Apixaban in Thai Non-valvular Atrial Fibrillation Patients

NCT04684732 ·Status: UNKNOWN

Study to Determine the Response and Effectiveness of RSD1235 in Subjects With Atrial Fibrillation or Atrial Flutter

NCT00115791 ·Status: COMPLETED ·Phase: PHASE3

Assessment of Thrombotic Status in Patients With Atrial Fibrillation

NCT02583971 ·Status: UNKNOWN

Intravenous Cardioversion of Atrial Fibrillation (AF) With AZD1305

NCT00915356 ·Status: COMPLETED ·Phase: PHASE2

Prevention Of Recurrence Of Atrial Fibrillation

NCT00041496 ·Status: COMPLETED ·Phase: PHASE2

Atrial Fibrillation Burden and Long-term Risk of Thromboembolic Complications- the FinCV-4 Study

NCT04001205 ·Status: ACTIVE_NOT_RECRUITING

Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart Rhythm

NCT00911300 ·Status: COMPLETED ·Phase: PHASE2

Study on Left Atrial Function of Atrial Fibrillation After Radiofrequency Ablation With Statin Therapy

NCT02776956 ·Status: COMPLETED ·Phase: NA

Treatment and Outcomes of Atrial Fibrillation and Acute Coronary Syndrome in Sweden

NCT03311139 ·Status: COMPLETED

Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis

NCT03987711 ·Status: COMPLETED ·Phase: PHASE2